Professor Simpson is holds a BSc (Hons) and a PhD from the University of Sydney and has been the Professor of Biochemistry, University of Technology Sydney since 2002. Her main research interest is the gene therapy of T1D focussing on the production of surrogate β-cells primarily from liver.

Karki A is a PhD candidate with over seven years of experience in public health and chronic disease research in Nepal and Australia. Karki is passionate about advancing public health and well-being through the application of implementation science and translating research into real-world practice.

Belinda Yau is a postdoctoral research fellow in the Islet Biology and Metabolism laboratory at the Charles Perkins Centre. Her research focuses on the physiology and function of insulin secretory granules, primarily in the context of beta-cell dysfunction in diabetes.

Dr Tuch is a translational endocrinologist pursuing a cell therapy for type 1 diabetes using stem cell differentiated islets without the need for systemic immunosuppression. He is adjunct Professor at Monash University and is a founder of the NSW Stem Cell Network.

Cameron Evans, PhD student at the Kolling Institute, University of Sydney, explores repurposing TGA-approved drugs for diabetic foot ulcers and peripheral artery disease, using animal models, human tissue, and cells. He is jointly supervised by A/Prof Sarah Glastras and Prof Gemma Figtree.

Nan Su is a PhD candidate in at The University of Melbourne. Her research focuses on SGLT2 expression and cardioprotective mechanisms in diabetogenic iPSC-models. Nan has presented at multiple conferences and was awarded Best Poster in Basic Science Discipline at ACMD 2024 .